ATE546427T1 - Acyloxyalkylcarbamat-prodrugs, syntheseverfahren und anwendung - Google Patents
Acyloxyalkylcarbamat-prodrugs, syntheseverfahren und anwendungInfo
- Publication number
- ATE546427T1 ATE546427T1 AT04781926T AT04781926T ATE546427T1 AT E546427 T1 ATE546427 T1 AT E546427T1 AT 04781926 T AT04781926 T AT 04781926T AT 04781926 T AT04781926 T AT 04781926T AT E546427 T1 ATE546427 T1 AT E546427T1
- Authority
- AT
- Austria
- Prior art keywords
- acyloxyalkylcarbamat
- prodrugs
- application
- synthesis method
- group
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 238000001308 synthesis method Methods 0.000 title 1
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- -1 acyloxyalkyl carbamate Chemical compound 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000001148 spastic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49693803P | 2003-08-20 | 2003-08-20 | |
| US60663704P | 2004-08-13 | 2004-08-13 | |
| PCT/US2004/027330 WO2005019163A2 (en) | 2003-08-20 | 2004-08-20 | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE546427T1 true ATE546427T1 (de) | 2012-03-15 |
Family
ID=36762986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04781926T ATE546427T1 (de) | 2003-08-20 | 2004-08-20 | Acyloxyalkylcarbamat-prodrugs, syntheseverfahren und anwendung |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1660440B1 (de) |
| JP (3) | JP5148874B2 (de) |
| CN (2) | CN1860101B (de) |
| AT (1) | ATE546427T1 (de) |
| CA (1) | CA2536257C (de) |
| CY (1) | CY1112827T1 (de) |
| ES (1) | ES2382000T3 (de) |
| IL (1) | IL173826A (de) |
| NO (1) | NO335606B1 (de) |
| NZ (1) | NZ545719A (de) |
| PL (1) | PL1660440T3 (de) |
| RU (2) | RU2423347C2 (de) |
| SG (1) | SG145759A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE546427T1 (de) * | 2003-08-20 | 2012-03-15 | Xenoport Inc | Acyloxyalkylcarbamat-prodrugs, syntheseverfahren und anwendung |
| ES2601852T3 (es) * | 2008-01-25 | 2017-02-16 | Xenoport, Inc. | Forma cristalina de sales de calcio de ácidos (3S)-aminometil-5-metil-hexanoicos y métodos de uso |
| EP3674289B9 (de) * | 2017-08-25 | 2023-12-13 | Guangzhou Henovcom Bioscience Co., Ltd | Langwirkendes rasagilin-prodrug, herstellungsverfahren und verwendung davon |
| CN107805202A (zh) * | 2017-12-01 | 2018-03-16 | 内蒙古圣氏化学股份有限公司 | 一种氯甲基异丙基碳酸酯连续化反应装置及方法 |
| WO2024046279A1 (zh) * | 2022-08-29 | 2024-03-07 | 广州市恒诺康医药科技有限公司 | 一种mao-b抑制剂前药的多晶型及其制备方法和用途 |
| CN116870899B (zh) * | 2023-06-08 | 2025-06-20 | 桂林理工大学 | 一种基于锰化合物的具有类漆酶活性的纳米酶合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3475065D1 (en) * | 1983-06-23 | 1988-12-15 | Merck & Co Inc | (acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives |
| SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
| GB2365425A (en) * | 2000-08-01 | 2002-02-20 | Parke Davis & Co Ltd | Alkyl amino acid derivatives useful as pharmaceutical agents |
| CA2449729C (en) * | 2001-06-11 | 2009-11-03 | Xenoport, Inc. | Prodrugs of gaba analogs, compositions and uses thereof |
| ATE546427T1 (de) * | 2003-08-20 | 2012-03-15 | Xenoport Inc | Acyloxyalkylcarbamat-prodrugs, syntheseverfahren und anwendung |
-
2004
- 2004-08-20 AT AT04781926T patent/ATE546427T1/de active
- 2004-08-20 CA CA2536257A patent/CA2536257C/en not_active Expired - Fee Related
- 2004-08-20 NZ NZ545719A patent/NZ545719A/en not_active IP Right Cessation
- 2004-08-20 RU RU2006108541/04A patent/RU2423347C2/ru not_active IP Right Cessation
- 2004-08-20 PL PL04781926T patent/PL1660440T3/pl unknown
- 2004-08-20 JP JP2006524109A patent/JP5148874B2/ja not_active Expired - Fee Related
- 2004-08-20 CN CN2004800283518A patent/CN1860101B/zh not_active Expired - Fee Related
- 2004-08-20 SG SG200806169-9A patent/SG145759A1/en unknown
- 2004-08-20 ES ES04781926T patent/ES2382000T3/es not_active Expired - Lifetime
- 2004-08-20 EP EP04781926A patent/EP1660440B1/de not_active Expired - Lifetime
- 2004-08-20 CN CN201010221620XA patent/CN101914040A/zh active Pending
-
2006
- 2006-02-20 IL IL173826A patent/IL173826A/en active IP Right Grant
- 2006-03-20 NO NO20061268A patent/NO335606B1/no not_active IP Right Cessation
-
2010
- 2010-11-23 RU RU2010147826/04A patent/RU2010147826A/ru not_active Application Discontinuation
-
2011
- 2011-07-25 JP JP2011162504A patent/JP2011256182A/ja active Pending
-
2012
- 2012-05-02 CY CY20121100410T patent/CY1112827T1/el unknown
- 2012-08-03 JP JP2012173119A patent/JP2013006842A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NO20061268L (no) | 2006-05-22 |
| JP2013006842A (ja) | 2013-01-10 |
| CN1860101B (zh) | 2010-10-27 |
| IL173826A (en) | 2014-07-31 |
| PL1660440T3 (pl) | 2012-07-31 |
| RU2010147826A (ru) | 2012-05-27 |
| CN1860101A (zh) | 2006-11-08 |
| CA2536257C (en) | 2012-01-03 |
| ES2382000T3 (es) | 2012-06-04 |
| CN101914040A (zh) | 2010-12-15 |
| JP2007521318A (ja) | 2007-08-02 |
| EP1660440A2 (de) | 2006-05-31 |
| JP2011256182A (ja) | 2011-12-22 |
| RU2006108541A (ru) | 2007-09-27 |
| HK1090912A1 (en) | 2007-01-05 |
| JP5148874B2 (ja) | 2013-02-20 |
| NZ545719A (en) | 2010-03-26 |
| IL173826A0 (en) | 2006-07-05 |
| CY1112827T1 (el) | 2016-02-10 |
| CA2536257A1 (en) | 2005-03-03 |
| SG145759A1 (en) | 2008-09-29 |
| RU2423347C2 (ru) | 2011-07-10 |
| NO335606B1 (no) | 2015-01-12 |
| EP1660440B1 (de) | 2012-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112827T1 (el) | Προφαρμακα καρβαμιδικου ακυλοξυαλκυλεστερα, μεθοδοι συνθεσης και χρηση | |
| NO20060847L (no) | Substituert 2-aminotetralin til behandling av depresjon | |
| MX2009008439A (es) | Nuevos inhibidores de la replicacion del virus de hepatitis c. | |
| NO20083005L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av smerte | |
| NO20076508L (no) | Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav | |
| EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
| EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
| EP2349279A4 (de) | Aldehyddehydrogenase-modulatoren und anwendungsverfahren dafür | |
| CY1109519T1 (el) | Κεκορεσμενες και ακορεστες 3-πυριδυλο-βενζοκυκλοαλκυλομεθυλαμινες για τη θεραπεια πονων, καταθλιψεων και καταστασεων φοβου | |
| UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
| WO2009134616A3 (en) | Novel inhibitors of hepatitis c virus replication | |
| WO2009015485A8 (en) | Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer | |
| UA107562C2 (uk) | Спосіб лікування псоріазу | |
| SE0401969D0 (sv) | Piperidine derivatives | |
| JP2010520242A5 (de) | ||
| NO20092018L (no) | Fremgangsmater for a behandle depresjon | |
| NZ585338A (en) | Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof | |
| ATE464895T1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen | |
| DK2155736T3 (da) | Ny carbamoyloxyarylalkanoylarylpiperazin- forbindelse, farmaceutiske sammensætninger, omfattende forbindelsen og fremgangsmåde til behandling af smerte, angst og depression ved indgivelse af forbindelsen | |
| ATE451922T1 (de) | Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren | |
| EA200600502A1 (ru) | Способ асимметрической гидрогенизации бета-аминокетонов | |
| SE0401968D0 (sv) | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof | |
| WO2007120079A3 (fr) | Dérivés de 4-aminométhyl-6-brome-5-hydroxyindol-3-carboxylates | |
| WO2008107501A8 (es) | Composition para el tratamiento de enfermedades infecciosas causadas por helicobacter | |
| EA201071335A1 (ru) | Способ ухода за волосами |